InVivo Therapeutics Holdings Corp. Stock price

Equities

NVIV

US46186M6057

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 02:01:36 2024-03-27 pm EDT 5-day change 1st Jan Change
0.2103 USD +0.05% Intraday chart for InVivo Therapeutics Holdings Corp. -19.12% -71.19%
Sales 2021 - Sales 2022 - Capitalization 4.5M
Net income 2021 -9M Net income 2022 -10M EV / Sales 2021 -
Net cash position 2021 17.72M Net cash position 2022 15.4M EV / Sales 2022 -
P/E ratio 2021
-1.52 x
P/E ratio 2022
-0.34 x
Employees 6
Yield 2021 *
-
Yield 2022
-
Free-Float 89.35%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.05%
1 week-19.12%
Current month-27.48%
1 month-28.71%
3 months-71.95%
6 months-81.55%
Current year-71.19%
More quotes
1 week
0.20
Extreme 0.2
0.27
1 month
0.15
Extreme 0.15
0.30
Current year
0.15
Extreme 0.15
1.05
1 year
0.15
Extreme 0.15
1.64
3 years
0.15
Extreme 0.15
27.25
5 years
0.15
Extreme 0.15
1 267.50
10 years
0.15
Extreme 0.15
369 000.23
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 17-07-04
Director of Finance/CFO 54 19-01-13
General Counsel - 17-07-11
Members of the board TitleAgeSince
Director/Board Member 57 16-06-07
Director/Board Member 67 19-11-07
Chairman 73 14-11-10
More insiders
Date Price Change Volume
24-03-27 0.2103 +0.05% 2,180
24-03-26 0.2102 -19.15% 273,538
24-03-25 0.26 0.00% 5,230
24-03-22 0.26 0.00% 13,605
24-03-21 0.26 0.00% 38,049

Delayed Quote OTC Markets, March 27, 2024 at 02:01 pm EDT

More quotes
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.
More about the company
  1. Stock
  2. Equities
  3. Stock InVivo Therapeutics Holdings Corp. - OTC Markets